Literature DB >> 23120289

Hypohidrotic (Anhidrotic) Ectodermal dysplasia - A rare cause of childhood Atrophic Rhinitis".

S Das Gupta1, K S Dasgupta, Samir V Joshi, Kanchan Lanjewar, Neeraj Murkey, Surendra H Gawarle, N S N Murkey, Atul Avad.   

Abstract

Hypohydrotic (Anhidrotic) Ectodermal dysplasia is a rare hereditary genodermatosis characterized by a triad of defects including hypohidrosis hypotrichosis and anomalous dentition. Mainly ectodermal structures are involved such as epidermis and its annexes (hair & nails), although non-ecotodermal tissue may also became involved(1). ENT involvement in such cases is a consequence of the defect involving the eccrine and sebaceous glands. A case of a 3 years old female child suffering from hypohidrotic ectodermal dysplasia with features of Atrophic Rhinitis from infancy & early childhood is reported here. Management of these patients is mainly supportive and otolaryngologist is a vital component of the health care team managing such patients.

Entities:  

Keywords:  Atrophic Rhinitis; Hypohidrotic Ectodermal Dysplasia

Year:  2006        PMID: 23120289      PMCID: PMC3450788          DOI: 10.1007/BF03050792

Source DB:  PubMed          Journal:  Indian J Otolaryngol Head Neck Surg        ISSN: 2231-3796


  4 in total

1.  [Anhidrotic ectomermal dysplasia (AED): four cases].

Authors:  E Soubeyrand; J Nicolas; D Labbé; S Riscala; L Olive; J-F Compère; H Bénateau
Journal:  Rev Stomatol Chir Maxillofac       Date:  2005-12

2.  On the distribution of frequencies of mutation to genes determining harmful traits in man.

Authors:  A C Stevenson; C B Kerr
Journal:  Mutat Res       Date:  1967 May-Jun       Impact factor: 2.433

3.  [ENT expression of hypohidrotic ectodermal dysplasia].

Authors:  J González García; H Galera Ruiz; F Muñoz Borge
Journal:  Acta Otorrinolaringol Esp       Date:  2005-04

4.  Ectodermal dysplasia: otolaryngologic manifestations and management.

Authors:  Elena Daniel; Elizabeth A McCurdy; Vandana Shashi; William F McGuirt
Journal:  Laryngoscope       Date:  2002-06       Impact factor: 3.325

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.